
RWEsearch and Health Innovation Summit 2025
Shaping the Future of Healthcare Through Clinical Research, Innovation and Real-World Evidence

Countdown Expired!
Setting the Tone for What’s Next
After a successful first edition, RWEsearch has established itself as a trusted platform for global conversations on data, research and innovation by bringing together decision-makers, innovators, and changemakers across healthcare, life sciences, and public health.
Glimpse of the RWEsearch Summit 2025
1800+
Registrations
45+
Speakers
1100+
Attendees
10+
Countries
190+
Cities Acrosss India
30+
Organizations Participated
18+
Sessions
62.9
Net Promoter Score

1800+
REGISTRATIONS

45+
SPEAKERS

1100+
ATTENDEES

10+
countries

190+
cities ACROSS INDIA

30+
ORGANIZATIONS PARTICIPATED

18+
SESSIONS

62.9
NET PROMOTER SCORE
Inside RWEsearch & Health Innovation 2025
Improving Diversity in Clinical Trials
Improving Diversity in Clinical Trials
Validating Fit-for-Purpose Data in the Era of AI
Validating Fit-for-Purpose Data in the Era of AI
AI and Automation
AI and Automation
Changing Markets
Changing Markets
Scaling Healthcare Innovation
Scaling Healthcare Innovation
This session will explore how Indian GCCs are taking local healthcare innovations to a global scale. We’ll dive into how these centers are using telemedicine, AI, & cloud-based platforms to make healthcare more accessible & efficient. Key topics will include improving patient outcomes, reducing costs, & scaling solutions to both urban & rural areas, especially in emerging markets
Agentic AI in Healthcare
Agentic AI in Healthcare
Finance & Procurement Innovation
Finance & Procurement Innovation
Talent-Related Opportunities & Challenges
Talent-Related Opportunities & Challenges
Leveraging Tier 2 Cities for Innovation
Leveraging Tier 2 Cities for Innovation
Building Sustainable Healthcare Solutions
Building Sustainable Healthcare Solutions
Bridging the Digital Divide in Healthcare
Bridging the Digital Divide in Healthcare
The Future of AI-Driven Healthcare in Indian GCCs
The Future of AI-Driven Healthcare in Indian GCCs
RWE & Digital Health in Africa
RWE & Digital Health in Africa
Enhancing Representation in Clinical Trials
Enhancing Representation in Clinical Trials
AI-Driven Healthcare Transformation in Africa
AI-Driven Healthcare Transformation in Africa
Public-Private Partnerships Fueling Innovation in Africa
Public-Private Partnerships Fueling Innovation in Africa
RWE & Digital Health in the Middle East
RWE & Digital Health in the Middle East
AI’s Impact on Middle East Healthcare
AI’s Impact on Middle East Healthcare
The Middle East: Rising MedTech & Diagnostics Powerhouse
The Middle East: Rising MedTech & Diagnostics Powerhouse
Inside RWEsearch & Health Innovation 2025
Improving Diversity in Clinical Trials
Improving Diversity in Clinical Trials
Validating Fit-for-Purpose Data in the Era of AI
Validating Fit-for-Purpose Data in the Era of AI
AI and Automation
AI and Automation
Changing Markets
Changing Markets
Who Should Attend?
- RWE Analysts / Consultants
- Big Data Consultants
- Life Science Consultants
- Health Economists
- Health Informatics Specialists
- Research Associates
- Clinical Research Scientists
- Clinical Research Coordinators
- Clinical Trial Managers
- Data Scientists/ Analysts
- Biostatisticians
- Health Data Analysts
- Regulatory Affairs Specialists
- Compliance Officers
- Ethics Committee Members
- Health Outcomes Researchers
- Health Policy Analysts
- Health IT Professionals
- Software Developers (focused on health and data solutions)
- Government Health Officials
- Policy Advisors
- Public Health Administrators
- Medical Writers
Why Sponsor Us?
Position your organization as a leader in Digital Health, Research and Technology through high-impact visibility, curated engagement, and targeted brand exposure
Visibility
Your Voice
Voices from the Community
This summit is an incredible opportunity to explore the latest trends and advancements in Real-World Evidence.
India is already and will continue to be one of the largest contributors to the global workforce for influencing health outcomes.”
The sessions were packed with valuable information and insights we can apply today. We've had our eyes opened to developments happening much sooner than anticipated.
You don’t usually get this mix with academics, regulators, startups, and commercial leads in one conversation. That cross-pollination was incredibly refreshing.
Most of the data available to us is based on insurance claim statements, leaving out a significant portion of the underinsured and currently unrepresented. We need to capture more diverse and complete data to better represent these vulnerable groups
RWE & Digital Health Innovation Expertise -
Beyond the Summit
RWEsearch Summit 2025 Agenda
Hall Details | Timings (IST) | Theme | Speakers |
---|---|---|---|
Hall A | 7-7:15pm | Welcome Note | Sudeep Krishna (Healthark) Janak Joshi (Commonwealth of Massachusetts) |
7:30-8:00pm | Welcome Keynote by Honorable Minister of IT of Telangana | Shri D. Shridhar Babu (Govt. of Telangana) | |
8:00-9:00pm | AgenticAI & Automation at LS GCCs: Past, Present & Future | John Dawber (Novo Nordisk) | |
Mohit Dhingra (Bristol Myer Squibb) | |||
Nilay Shashtri (Roche) | |||
Mahesh Natranjan (Thermo Fisher Scientific) | |||
Moderator- Sudeep Krishna (Healthark) | |||
9:30-10:15pm | Keynote Address: RWE Benchmarking Survey: Insights into Real-World Evidence Adoption | Keynote Speaker: Brett Davis (Deloitte) | |
Keynote Speaker: Jeffery Morgan (Deloitte) | |||
Hall B | 8:00 – 8:45pm | Future of Healthcare Education in India: Serving India & The World | Dr Somen Saha (IIPHG) |
PR Sodani (IIHMR University) | |||
Neha Sadhotra (NMIMS) | |||
Moderator: Kalyan Kalyanraman (The Hindu Group) | |||
8:45-9:15 pm | Healthcare Innovation in India – The NHA perspective | Dr. Ruchira Agrawal (National Health Authority) | |
Hall C | 9-9:30pm | Students perspective on Health Education | Students |
Hall Details | Timings (IST) | Theme | Speakers |
---|---|---|---|
Hall A | 7:00 – 7:15 pm | Welcome | Dr Purav Gandhi (Healthark) Julie Krammenhoek (RWE companies) |
7:15 – 8:00 pm | Bridging the Equity Gap: RWE Strategies to Improve Representation Across Diverse Populations | Phani Veeranki (Optum) | |
Ashley Jaksa (Target RWE) | |||
Grace McNamara (Elfie) | |||
Moderator:Janak Joshi (Commonwealth of Massachusetts) | |||
8 – 8:30pm | Innovations in Real World Evidence | Keynote: Sandipan Bhattacharjee (ISPOR, Bayer) | |
8:30-9:30pm | Real World Wednesdays Podcast | Aaron Kamauu (Navidence) | |
Matt Veatchh (Navidence) | |||
9:30-10:30pm | Real World Wednesdays Panel | Stuart McCully (RWE Regs) | |
Radek Wasiak (Adigens Health) | |||
Charlie Barr (Adaptic Health) | |||
Moderator: Aaron Kamauu (Navidence) | |||
Moderator: Matt Veatchh (Navidence) | |||
Hall B | 7:15-8pm | Commercial Realities: Ensuring Fit-for-Purpose and Diverse RWD Strategies for Small Biotechs vs. Big Pharma | Ben M.W Illigens (Data4Life) |
Rajinder Sobti (Deloitte) | |||
Dan Posover (Graticule) | |||
Moderator – Jeff Trotter (J Trotter Research and Consulting) | |||
8 – 8:30pm | Innovative Pharma Case Studies – The Elfie Perspective | Jean-François LEGOURD (Elfie) | |
8:30 – 9:15pm | Fit for purpose data vs AI ready data – What’s the right RWE approach? | Melinda Baker (Picnic Health) | |
Dr Kavita Lamror (Maxxis Clinical Research) | |||
David Gascoigne (Segmed) | |||
Moderator: Alessandra Oortwijn (Alfasigma) | |||
9:15-10:15pm | The ISPOR Perspective | Clarissa Cooblall (ISPOR) | |
Madeline Shipley (ISPOR) | |||
Doug Foster (ADS) | |||
Moderator: Dr Purav Gandhi (Healthark) | |||
Hall C | 7:15 – 8:00pm | Fireside chat with Miltenyi | Priya Kapoor G Hingorani (Miltenyi) |
Moderator: Sudeep Krishna (Healthark) | |||
8:45 – 9:30pm | Transforming clinical trials with AI | Troy Astorino (PicnicHealth) | |
David Hall (AKT Health) | |||
Madhav Vattikuti (Perceptive) | |||
Dan Housman (Graticule) | |||
Moderator: Julie Krammenhoek (Co-Chair) | |||
9:30 – 10:00pm | Opportunities & Challenges with RWiD | Dr Martin Willemink (Segmed) |
Hall Details | Timings (IST) | Theme | Speakers |
---|---|---|---|
Hall A | 7-7:15pm | Welcome Note | Dr Purav Gandhi (Healthark) Sudeep Krishna (Healthark) |
7:15-8:00pm | Use of AI to Transform Healthcare in Africa | Salma Mahmoud | |
Mohamed Okba (Otsuka Pharmaceuticals) | |||
Haytham Elgazzar (CRDMI) | |||
Dr. Ida Mbuthia (Roche) | |||
Moderator:Janak Joshi (Commonwealth of Massachusetts) | |||
8:00-9:00pm | Innovation in Evidence Generation to Accelerate the Impact of Digital Health Solutions in the Middle East | Dr Ruth Jacob (Cepheid) | |
Sophie Smith (Nabta Health) | |||
Dr Akram Bouchenaki (GenPharm) | |||
Moderator: Galina Osina (Ex- Roche) | |||
9:00 – 9:45pm | RWE & Digital Health in Africa: Opportunities, Challenges, and the Path Forward | Ranin Soliman (World Health Organization) | |
Moderator: Shereef Ibrahim (Menarini Group) | |||
Ali Jeremi (Roche) | |||
Amina Rafiki (Gilead) | |||
Lamees Elshahawy (J&J) | |||
9:45-10:30pm | Data readiness as a foundation for AI in healthcare – The Data First, AI Later perspective | Moderator: Paul Nunesdea (Data First AI Later) | |
Dr. Padmavathi Roy (Data First AI Later) | |||
Dr. Dipak Kalra (The European Institute for Innovation through Health Data) | |||
Hall B | 7:15 – 8:00pm | Fundamentals, Present State & Future of Personalized Cell Therapy | Dr. Prudwidhar (Miltenyi) |
8:00 – 8:45pm | Next-Gen V&V for Medical Devices: Adapting to AI, Digital Health, and Real-World Evidence | Dilip Kumar (Philips) | |
Syed Akmal (Thermo Fisher Scientific) | |||
Moderator: Dhaval Vasavada | |||
Hall C | 7:15 – 8:00pm | Student Hackthon Presentation | Finalists |
Our Esteemed Speakers

Janak Joshi
Dpty. Chief Digital Officer
Commonwealth of Massachusetts

Julie Krommenhoek
Strategic & PE Advisor | Life Sciences
RWE & Health Tech Companies

Brett Davis
US Chief Innovation Officer


Jean-Francois Legourd
Co-founder & COO


Jeffrey Morgan
Managing Director


Sandipan Bhattacharjee
Director Real World Evidence (RWE) Leader Oncology, Chair, RWE SIG at ISPOR


Aaron Kamauu
Co Founder & CEO


Alessandra Oortwijn
Global Head Evidence Generation, Medical Affairs


Ali Jeremi
Medical Value Lead


Dr. Anish Sinha
Registrar


Ashley Jaksa
VP Evidence Solutions
Ex-Aetion

Ben M.W. Illigens
Chief Executive Officer


Charlie Barr
Chief Medical Officer & Co-Founder


Clarissa Cooblall
Director, Scientific and Patient Initiatives


David Gascoigne
Chief Executive Officer


David Hall
MD, Chief Investment Officer (CIO) AKT Capital


Dilip Kumar
R&D Leader


Dipak Kalra
President


Doug Foster
Partner


Galina Osina
Independent Consultant
Ex-Roche

Grace McNamara
Partnerships Director


Haytham Elgazzar
Associate Professor


Hitendra Purohit
Senior Manager R&D


Dr. Ida Mbuthia
Healthcare Access Chapter Lead Africa


Jeff Trotter
Principal


John Dawber
Corporate Vice President & Managing Director
Novo Nordisk

Kalyan Kalyanaraman
Associate Editor


Dr. Kavita Lamror
Partner, RWE & Digital Transformation


Lamees Elshahawy
Medical Affairs Manager


Madeline Shipley
Scientific and Health Policy Initiatives Manager


Madhav Vattikuti
SVP Technology & GM India


Mahesh Natarajan
Director


Dr. Martin Willemink
Co-Founder & Chief Scientific Officer


Matt Veatch
Co-founder & COO


Melinda Baker
Director of Dataset Strategy & Commercialization


Mohamed Okba
Head of Regulatory & Public Affairs & HEOR


Mohit Dhingra
Managing Director at Bristol Myers Squibb India, Hyderabad


Neha Sadhotra
Founding Chairperson


Nilay Shastri
General Manager


Paul Nunesdea
Firestarter


Phani Veeranki
Senior Director & Principal Consultant


PR Sodani
President


Radek Wasiak
Co-Founder, Director


Ranin Soliman
Evidence & Data-to-Policy Consultant


Dr. Ruchira Agrawal
Head & Principal Consultant


Dr. Ruth Jacob
Government Affairs Market Access HEOR EMEA Lead


Shereef Ibrahim
MEA Medical Manager


Sophie Smith
Founder and CEO


Stuart McCully
Co-Founder


Troy Astorino
Co-Founder & Chief Technology Officer

Speaker Representations



































I walked in expecting another RWE panel. What I didn’t expect was such a global, practical, and refreshingly candid discussion. It wasn’t just academic, rather it was actionable.